U.S. shares have been increased, with the Dow Jones index gaining round 200 factors on Wednesday.
Shares of Dynavax Applied sciences Corp (NASDAQ:DVAX) rose sharply throughout Wednesday’s session after Sanofi SA (NASDAQ:SNY) agreed to accumulate the corporate for $15.50 per share in money, reflecting a complete equity value of approximately $2.2 billion.
The acquisition augments Sanofi’s presence in grownup immunization.
Dynavax shares jumped 38.6% to $15.44 on Wednesday.
Listed below are another large shares recording good points in at this time’s session.
- Omeros Corp (NASDAQ:OMER) shares jumped 66.8% to $14.60 after the FDA accredited YARTEMLEA to deal with hematopoietic stem cell transplant–related thrombotic microangiopathy.
- Edgewise Therapeutics Inc (NASDAQ:EWTX) gained 23.8% to $26.94. Edgewise Therapeutics on Wednesday shared updates from the continued CIRRUS-HCM Part 2 trial of EDG-7500.
- Agios Prescribed drugs Inc (NASDAQ:AGIO) surged 17.9% to $29.00 after the corporate introduced the FDA accredited AQVESME for the remedy of anemia in adults with alpha- or beta-thalassemia. An exect introduced AQVESME can be introduce at roughly $425,000 per affected person per yr.
- Wheels Up Expertise Inc (NYSE:UP) gained 14.8% to $0.73.
- Travere Therapeutics Inc (NASDAQ:TVTX) gained 14.3% to $40.41.
- Coincheck Group NV (NASDAQ:CNCK) surged 12.5% to $2.88.
- Polestar Automotive Holding Uk Plc (NASDAQ:PSNY) jumped 11.8% to $16.92. Polestar Automotive just lately introduced a $300 million fairness funding from Banco Bilbao Vizcaya Argentaria and Natixis.
- CapsoVision Inc (NYSE:CV) gained 11.6% to $14.39.
- X4 Prescribed drugs Inc (NASDAQ:XFOR) gained 9.5% to $4.52.
- Falcon’s Past International Inc (NASDAQ:FBYD) jumped 9.4% to $18.35. Falcon’s Past International just lately introduced submitting of a $100 million blended shelf providing.
- BIOAGE Labs Inc (NASDAQ:BIOA) jumped 8.8% to $14.37.
- Kodiak Sciences Inc (NASDAQ:KOD) gained 8.6% to $29.81.
- UiPath Inc (NYSE:PATH) jumped 7.9% to $17.23 after it was introduced that it’s going to exchange Synovus Monetary within the S&P MidCap 400.
- Immuneering Corp (NASDAQ:IMRX) rose 6.8% to $6.83. Immuneering introduced that it will present an replace on 12-month general survival from its ongoing Part 2a medical trial of atebimetinib + mGnP in first-line pancreatic most cancers sufferers, on January 7, 2026.
- Nike Inc (NYSE:NKE) gained 4.7% to $60.03 as traders weighed a notable insider buy in opposition to ongoing issues round tariffs, China demand, and a slower-than-expected turnaround.
- Micron Know-how Inc (NASDAQ:MU) gained 3.5% to $286.01.
Learn This Subsequent:
Photograph by way of Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
